Normally, the folks at GlaxoSmithKline keep us tightly in the loop when there's news. So, I'm a bit surprised that it took a "tweet" on Twitter this morning to learn that four days ago the company put out a press release that has "Pharma's Market" written all over it.
Japan and Januvia. No, it's not a country—not even a fictional one—even though it sounds like "Genovia" in "The Princess Diaries." It's a diabetes drug from Merck.
The number of job cuts continued to soar in February 2009, reflecting the worsening US recession.
More companies announced layoffs this week as the employment picture continued to dim. JPMorgan Chase and Chesapeake Energy were among the latest names on Thursday to announce job cuts.
Vinesh writes, “What is the reason why the Exxon stock is not doing well lately. Crude oil is going up where as Exxon share price is not keeping pace with the increase in crude?"
Another round of layoffs was announced on Thursday, adding to the gloom over rising unemployment. Delta Air Lines and Performance Food Group were among the latest names on Wednesday to announce job cuts.
Instead of asking what Warren Buffett has been buying, we should have been wondering what he's been selling. Berkshire Hathaway's stock portfolio snapshot for the end of the fourth quarter reveals its holdings in Johnson and Johnson have been slashed by more than half.
Another round of layoffs was announced on Tuesday, adding to the gloom over rising unemployment.
Friday the 13th. My lucky day for reaching into the Pharma's Market mailbag. Time for your Emails.
Another round of layoffs was announced on Thursday, adding to the gloom over rising unemployment.
More companies announced layoffs this week as the employment picture continued to dim. News Corp. became the latest victim of the weakening economy, announcing it is planning on cutting jobs after reporting a quarterly loss on Thursday.
More companies announced layoffs this week as the employment picture continued to dim. GlaxoSmithKline and Tiffany & Co. on Thursday became the latest victims of the weakening economy, each cutting an undisclosed number of jobs.
Stocks rallied on Thursday on hopes that the government's plan to shore up the financial system could quickly spark lending.
Retailers' January sales reports can't help but unleash a plethora of bad news ahead of Thursday's market open.
Swiss drug maker Roche sees growth slowing this year after its 2008 profit fell 5 percent and missed expectations, hurt by a loss of pandemic Tamiflu sales and the strong Swiss franc.
Before Gardasil came to market two to three years ago, some analysts were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things.
Dr. Steven Nissen, the cardiology chief at the Cleveland Clinic, reportedly remains on the shortlist to possibly become the next FDA Commissioner. Some analysts believe if Dr. Nissen gets the nod there could be a negative knee-jerk reaction in the big pharma sector stocks.
Cramer makes the call on viewers' favorite stocks in a special, extended Lightning Round, including PepsiCo, Verizon, Baidu, Boeing and others.
As we head into the holiday break and the bloggable newsflow slows to a trickle, I am digging into the overflowing mailbag while filling in for my vacationing colleague Scott Wapner at the Nasdaq this week.
Drugmaker Bristol-Myers Squibb said Tuesday it will eliminate another 10 percent of its work force through 2010 as it works to pare costs before it loses patent protection on key drugs.